Finally Drug the “Undruggable” Through Targeted Protein Degradation

As the most comprehensive, industry-focused and ‘must-attend’ event in the field, the 4th Targeted Protein Degradation Summit returns in October 2021 to once again explore the latest approaches, perspectives, and data-drive case studies that will continue to advance PROTACs, molecular glues, and other degrader modalities towards clinical success.

The 4th TPD Summit will unite 600+ biopharma and leading academic experts to capitalize on this emerging therapeutic class. We look forward to seeing the exciting advancements of degrader strategies in the clinic, discovering the latest translation and pre-clinical updates from the leaders in the space, and uncovering novel degrader modalities and approaches, which aim to make targeted protein degradation a truly blockbuster therapeutic in the quest to drug the undruggable.

Register your interest for our 2021 event to be first to find out about the new dates, expert speaker faculty, session details and more!

The 2020 Summit in Numbers:

2020 post event stats 2

A Snapshot of Confirmed 2021 Speakers:

2020 Attendees Included:

2020 attendees per

“TPD has expanded from a chemical biology tool to a therapeutic modality that redefines the “druggable” target landscape. This meeting will highlight key findings in the field of protein degradation and demonstrate the journey from degrader to therapeutic”

Jay Bradner, President, Novartis Institutes for Biomedical Research


2020 Partners Included:

Bio-Techne Logo
snipped logo
Nanome Logo

Other Events in the Undruggable Series